India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ntpc Ltd 132.05 0.04
Tata Mot 152.45 0.76
Tata Stl 480.40 2.31
Icici Ba 349.30 1.58
Tata Pow 65.70 4.30
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
11-Feb-2019       Glenmark Pharma gets nod for Sevelamer Hydrochloride tablets IRIS
07-Feb-2019       Glenmark Pharma gets tentative ANDA nod for Fulvestrant injection IRIS
23-Jan-2019       Glenmark Pharma gets tentative nod for Abiraterone Acetate tablets IRIS
10-Jan-2019       Glenmark Pharma enters into licensing agreement with Yuhan for commercializing Ryaltris in South Korea IRIS
19-Dec-2018       Glenmark Pharma forays into dermatology segment in U.S IRIS
18-Dec-2018       Glenmark Pharma gets nod for Fluocinolone Acetonide oil IRIS
17-Dec-2018       Glenmark Pharma gets final nod for Hydrocortisone Valerate ointment IRIS
26-Nov-2018       Glenmark Pharma gets tentative nod for Clobetasol propionate foam IRIS
22-Nov-2018       Glenmark Pharma receives ANDA approval for Atovaquone oral suspension IRIS
20-Nov-2018       Glenmark Pharma receives approval for Azelaic acid gel IRIS
16-Nov-2018       Glenmark Pharma gets USFDA approval for Teriflunomide tablets IRIS
01-Nov-2018       Glenmark Pharmaceuticals launches Nourkrin in Russia IRIS
30-Oct-2018       Glenmark Pharma receives nod for Fluocinolone Acetonide topical oil IRIS
26-Oct-2018       Glenmark Pharma gets nod for Fluocinolone Acetonide topical oil IRIS
19-Oct-2018       Glenmark Pharma to present data on investigational treatment for Atopic Dermatitis IRIS
16-Oct-2018       Glenmark Pharma gets nod for Hydrocortisone Valerate cream IRIS
19-Sep-2018       Glenmark Pharma inducted into DJSI Emerging Market 2018 IRIS
17-Sep-2018       Glenmark Pharma gets USFDA approval for generic VAGIFEM IRIS
10-Sep-2018       Glenmark gets marketing authorization for generic Seretide Accuhaler IRIS
29-Aug-2018       Glenmark Pharma to sell generic spiriva inhaler in Western Europe IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer